Caisse De Depot Et Placement Du Quebec Myriad Genetics Inc Transaction History

Caisse De Depot Et Placement Du Quebec

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$27.23 - $45.56 $7.24 Million - $12.1 Million	-265,819 Closed	0 $0
Q2 2018 Aug 13, 2018	SELL	$27.75 - $40.17 $948,522 - $1.37 Million	-34,181 Reduced 11.39%	265,819 $9.93 Million
Q1 2018 May 14, 2018	SELL	$28.83 - $41.01 $4.32 Million - $6.15 Million	-150,000 Reduced 33.33%	300,000 $8.87 Million
Q4 2017 Feb 13, 2018	BUY	$28.45 - $37.14 $5.69 Million - $7.43 Million	200,000 Added 80.0%	450,000 $15.5 Million
Q3 2017 Nov 13, 2017	BUY	$24.01 - $36.2 $6 Million - $9.05 Million	250,000	250,000 $9.08 Million

254

90.9M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.31B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Caisse De Depot Et Placement Du Quebec, based on Form 13F filings with the SEC.

Stay updated on Caisse De Depot Et Placement Du Quebec with notifications on news.